# Inovio Pharmaceuticals (INO) — Analyst Forecast

INO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ino/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 2 | 1 | 0 | 3 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 13, 2026 | Jefferies | Upgraded | Hold → Buy | $3.00 |
| Aug 3, 2026 | Piper Sandler | Maintained | Overweight | $4.00 |
| Jun 1, 2026 | HC Wainwright & Co. | Maintained | Neutral | $2.50 |
| Nov 14, 2025 | Piper Sandler | Maintained | Overweight | $6.00 |
| Aug 14, 2025 | HC Wainwright & Co. | Maintained | Neutral | $3.00 |
| Jul 9, 2025 | Piper Sandler | Initiated Coverage | Overweight | $5.00 |
| May 14, 2025 | Oppenheimer | Maintained | Outperform | $13.00 |
| May 14, 2025 | RBC Capital | Maintained | Sector Perform | $5.00 |
| Mar 19, 2025 | HC Wainwright & Co. | Maintained | Neutral | $3.00 |
| Mar 19, 2025 | RBC Capital | Maintained | Sector Perform | $5.00 |
| Mar 14, 2025 | Citizens Capital Markets | Maintained | Market Outperform | $18.00 |
| Jan 13, 2025 | HC Wainwright & Co. | Maintained | Neutral | $3.00 |
| Jan 10, 2025 | JMP Securities | Maintained | Market Outperform | $18.00 |
| Nov 18, 2024 | Oppenheimer | Maintained | Outperform | $15.00 |
| Nov 18, 2024 | HC Wainwright & Co. | Maintained | Neutral | $5.00 |
| Nov 15, 2024 | RBC Capital | Maintained | Sector Perform | $6.00 |
| Oct 4, 2024 | RBC Capital | Maintained | Sector Perform | $7.00 |
| Aug 12, 2024 | Oppenheimer | Maintained | Outperform | $33.00 |
| Aug 9, 2024 | RBC Capital | Maintained | Sector Perform | $8.00 |
| Jul 15, 2024 | HC Wainwright & Co. | Maintained | Neutral | $15.00 |

## Frequently Asked Questions

### Is INO a buy, sell, or hold?

Analysts covering Inovio Pharmaceuticals currently average a Buy rating: 2 buy, 1 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on INO?

On Aug 13, 2026, Jefferies upgraded Inovio Pharmaceuticals to Buy with a price target of $3.00.

## Similar Stocks

- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).